CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS
Yuanda Pharmaceutical Health Holdings Co., Ltd. is an investment holding company. Its subsidiaries are principally engaged in the development, manufacture and sale of pharmaceutical preparations, medical devices, pharmaceutical intermediates, specialty APIs and health products. The Group is committed to becoming one of the largest pharmaceutical and healthcare products manufacturing companies in China through its own business growth and acquisitions.
CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS
Industry:
Pharmaceutical
Founded:
1995-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Nginx Euro IPv6 Google Apps For Business GoDaddy DNS Google
Similar Organizations
Asia Resource Corp
Asia Resource Corp is a leading investment holding company.
Avalon Biomedical Management Ltd.
Avalon Biomedical Management Ltd. is an investment holding company
Camsing International Holdings
Camsing International Holdings is an investment holding company.
Guangzhou Zhong Shang Investment Holding Group
Guangzhou Zhong Shang is an Investment Holding Group
Hale Global
Hale Global is an investment holding company.
Harbin High-tech Group
Harbin High-tech Group is an investment holding company.
IDF Capital SA
IDF Capital SA an investments holding company
KBP Biosciences
A multinational clinical stage biotechnology company.
Rubicon Research
Rubicon Research is a pioneer Drug Delivery Technology company in India.
The Brain Protection Company
The Brain Protection Company is a clinical-stage company.
The Fit Company
The Fit Company is a holding company.
The J&J Group
The J&J Group is a South African Investment Holding Company.
Tuan Sing Holdings
The current name was adopted in 1983 and it has been an investment holding company .
Xinjiang Bai Hua Cun Company
Xinjiang Bai Hua Cun Company is a diversified holding company.
Yeo Hiap Seng
Yeo Hiap Seng is an investment holding company as well as a drink manufacturer.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-06-01 | Winguide Huangpu Pharmaceutical | Winguide Huangpu Pharmaceutical acquired by China Grand Pharmaceutical and Healthcare Holdings | 1.55 B CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-09 | Xeltis | China Grand Pharmaceutical and Healthcare Holdings investment in Series D - Xeltis | 15 M EUR |
| 2022-02-16 | Isotopen Technologien München | China Grand Pharmaceutical and Healthcare Holdings investment in Corporate Round - Isotopen Technologien München | 25 M EUR |
| 2022-01-27 | InnovHeart | China Grand Pharmaceutical and Healthcare Holdings investment in Series C - InnovHeart | 55 M USD |
| 2021-08-30 | Corisma | China Grand Pharmaceutical and Healthcare Holdings investment in Series A - Corisma | 27 M USD |
| 2020-06-16 | eTheRNA immunotherapies | China Grand Pharmaceutical and Healthcare Holdings investment in Series B - eTheRNA immunotherapies | 34 M EUR |
| 2020-04-17 | Cloudbreak Therapeutics | China Grand Pharmaceutical and Healthcare Holdings investment in Series B - Cloudbreak Therapeutics | 25.4 M USD |
More informations about "China Grand Pharmaceutical and Healthcare Holdings"
International - Grand Pharma Group
Our Group continued to implement the development strategy of “independent research and development + global expansion”, further exploring high-quality innovative projects around the world to expand the Group’s product pipeline …See details»
China Grand Pharmaceutical and Healthcare Holdings
Xeltis raised €32,000,000 / Series D from China Grand Pharmaceutical and Healthcare Holdings and 3 other investors Discover more funding rounds Funding Round • Aug 9, 2022See details»
China Grand Pharmaceutical & Healthcare | Company Overview
China Grand Pharmaceutical and Healthcare Holdings Ltd. engages in the development, manufacture and distribution of pharmaceutical products. The company was founded in 1995 …See details»
Update on China Grand Pharmaceutical and Healthcare Holdings …
Sydney, Australia 28 February 2022. Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company developing next-generation products to address the …See details»
China Grand Pharmaceutical and Healthcare Holdings
Apr 30, 2010 Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical …See details»
GP (HK) Enters into Strategic Cooperation with CoRISMA on Equity ...
(August 6, 2021 – Hong Kong) China Grand Pharmaceutical and Healthcare Holdings Limited (“GP (HK)” or the “Company”, together with its subsidiaries, the “Group”, stock code: 00512) is …See details»
Grand Pharmaceutical Group Company Description - Stock Analysis
Nov 26, 2024 It operates in the People’s Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand …See details»
China Grand Pharmaceutical and Healthcare Holdings
China Grand Pharmaceutical and Healthcare Holdings has acquired Winguide Huangpu Pharmaceutical on Jun 1, 2018. They acquired Winguide Huangpu Pharmaceutical for …See details»
China Grand Pharmaceutical and Healthcare Holdings
Dec 19, 1995 China Grand Pharmaceutical and Healthcare Holdings engages in the development, manufacture and distribution of pharmaceutical products.See details»
0512.HK - | Stock Price & Latest News | Reuters
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the …See details»
Grand Pharmaceutical Group Ltd, 512:HKG summary - FT.com
4 days ago Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally …See details»
Telix Pharmaceuticals Limited and China Grand Pharma Announce …
China Grand Pharmaceutical and Healthcare Holdings Executive Deputy Officer, Mr Frank Zhou added, “China Grand Pharma has a strong commitment to oncology, including radioactive …See details»
China Grand Pharmaceutical Latest From Country To Sell Stock
Aug 2, 2020 China Grand Pharmaceutical and Healthcare Holdings is looking to sell 172 million shares at HK$5.90 each, raising the equivalent of $130 million to fund research and …See details»
GP (HK) Announces 2020 Annual Results Profit - Grand Pharm
The Board of China Grand Pharmaceutical and Healthcare Holdings Limited, commented: “As the COVID-19 pandemic swept the world in 2020, the global economy has been hit hard. In order …See details»
China Grand Pharmaceutical and Healthcare Holdings Ltd
Oct 31, 2024 China Grand Pharmaceutical and Healthcare Holdings Ltd (SEHK:512) Market Cap as of today is 16.213 B. Compare the current Market Cap against historical performance …See details»
China Grand Pharmaceutical and Healthcare Holdings
Aug 14, 2023 Companies that could be attractive to China Grand Pharmaceutical and Healthcare Holdings for future investment are likely to be innovative firms within the healthcare …See details»
Woodbridge pharma company ChemWerth eyes overseas expansion
May 29, 2023 Acting as a broker between foreign manufacturers and U.S. drug companies, Woodbridge-based ChemWerth has grown from one man working in his garage into a …See details»
American Association of Pharmaceutical Scientists - AAPS
AAPS: Developing Science, Impacting Health. The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 10,000 members …See details»
Levitt Corp changes name to Woodbridge Holdings | Reuters
May 22, 2008 Levitt Corp <LEV.N> has changed its name to Woodbridge Holdings Corp following approval by shareholders at the May 20 annual meeting, the company said on …See details»
Woodbridge Opens New Site in China
Jul 27, 2022 New manufacturing plant to produce molded foam for Asia-Pacific customers. MISSISSAUGA, Ontario, Canada & TROY, Mich., July 27, 2022 – Woodbridge announces the …See details»